CN1768057A - 罗格列酮马来酸盐多晶型物的制备方法 - Google Patents

罗格列酮马来酸盐多晶型物的制备方法 Download PDF

Info

Publication number
CN1768057A
CN1768057A CNA2004800083916A CN200480008391A CN1768057A CN 1768057 A CN1768057 A CN 1768057A CN A2004800083916 A CNA2004800083916 A CN A2004800083916A CN 200480008391 A CN200480008391 A CN 200480008391A CN 1768057 A CN1768057 A CN 1768057A
Authority
CN
China
Prior art keywords
solvent
compound
rosiglitazone maleate
rosiglitazone
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800083916A
Other languages
English (en)
Chinese (zh)
Inventor
安德鲁·S·克雷格
罗伯特·G·吉勒斯
何鑑庭
迈克尔·J·萨斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CN1768057A publication Critical patent/CN1768057A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
CNA2004800083916A 2003-03-28 2004-03-25 罗格列酮马来酸盐多晶型物的制备方法 Pending CN1768057A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307259.2A GB0307259D0 (en) 2003-03-28 2003-03-28 Process
GB0307259.2 2003-03-28

Publications (1)

Publication Number Publication Date
CN1768057A true CN1768057A (zh) 2006-05-03

Family

ID=9955778

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800083916A Pending CN1768057A (zh) 2003-03-28 2004-03-25 罗格列酮马来酸盐多晶型物的制备方法

Country Status (18)

Country Link
US (1) US20070167494A1 (https=)
EP (1) EP1615918A1 (https=)
JP (1) JP2006521340A (https=)
KR (1) KR20050120670A (https=)
CN (1) CN1768057A (https=)
AU (2) AU2004224068A1 (https=)
BR (1) BRPI0408752A (https=)
CA (1) CA2520249A1 (https=)
EA (1) EA009331B1 (https=)
EC (1) ECSP056038A (https=)
GB (1) GB0307259D0 (https=)
IS (1) IS8087A (https=)
MA (1) MA27727A1 (https=)
MX (1) MXPA05010413A (https=)
NO (1) NO20054911L (https=)
OA (1) OA13042A (https=)
WO (1) WO2004085435A1 (https=)
ZA (1) ZA200507100B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
WO2018140092A1 (en) 2017-01-27 2018-08-02 Obrien Christopher F Methods for the administration of certain vmat2 inhibitors
ES3024958T3 (en) 2017-09-21 2025-06-05 Neurocrine Biosciences Inc High dosage valbenazine formulation and compositions, methods, and kits related thereto
JP2021502959A (ja) 2017-10-10 2021-02-04 ニューロクライン バイオサイエンシーズ，インコーポレイテッド 特定のｖｍａｔ２インヒビターを投与するための方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
UA67844C2 (uk) * 1999-04-23 2004-07-15 Смітклайн Бічам Плс Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти
PL351685A1 (en) * 1999-04-23 2003-06-02 Smithkline Beecham Plc Novel pharmaceutical
DE60004658T2 (de) * 1999-04-23 2004-06-24 Smithkline Beecham Plc, Brentford Thiazolidindionderivat und seine verwendung als antidiabetikum
CZ2003864A3 (cs) * 2000-09-26 2004-01-14 Dr. Reddy´S Research Foundation Nové polymorfní formy 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl]thiazolidin-2,4-dion-maleátu a způsob jejich přípravy

Also Published As

Publication number Publication date
OA13042A (en) 2006-11-10
IS8087A (is) 2005-10-24
EA200501527A1 (ru) 2006-02-24
EA009331B1 (ru) 2007-12-28
MXPA05010413A (es) 2005-11-04
BRPI0408752A (pt) 2006-03-28
ZA200507100B (en) 2006-07-26
NO20054911L (no) 2005-10-24
KR20050120670A (ko) 2005-12-22
AU2008237610A1 (en) 2008-11-27
US20070167494A1 (en) 2007-07-19
JP2006521340A (ja) 2006-09-21
AU2004224068A1 (en) 2004-10-07
WO2004085435A1 (en) 2004-10-07
EP1615918A1 (en) 2006-01-18
CA2520249A1 (en) 2004-10-07
MA27727A1 (fr) 2006-01-02
ECSP056038A (es) 2006-01-27
GB0307259D0 (en) 2003-05-07

Similar Documents

Publication Publication Date Title
CN1861604A (zh) 阿色纳品马来酸盐的晶型
CN1753874A (zh) 可用作肾上腺素受体激动剂的 5－′( r )－2－( 5 , 6－二乙基－茚满－2－基氨基)－1－羟基－乙基－8－羟基－(1h)－喹啉－2－酮盐的制备方法
CN1942439A (zh) 无定形形式的阿托伐他汀钙的制备方法
CN1845917A (zh) 3－[(2－{[4－(已氧基羰基氨基－亚氨基－甲基)－苯氨基]－甲基}－1－甲基－1 h－苯并咪唑－5－羰基)－吡啶－2－基－氨基]－丙酸乙酯－甲磺酸酯及其作为药物的用途
CN1208335C (zh) 噻唑烷二酮衍生物及其作为抗糖尿病药的用途
CN1198799C (zh) (s)－2－乙氧基－3－[4－(2－{4－甲磺酰氧基苯基}乙氧基)苯基]丙酸的晶形
CN1147516A (zh) 生物可利用的结晶形式头孢呋辛酯
CN1874998A (zh) 1－苄基－4－[(5,6－二甲氧基－1－二氢茚酮)－2－基]甲基哌啶草酸盐(多奈哌齐草酸盐)及其多晶型物
CN1378448A (zh) 多晶型托拉塞米
CN1768057A (zh) 罗格列酮马来酸盐多晶型物的制备方法
CN1349522A (zh) 2,2－二甲基－1,3－二氧杂环己烷中间体的盐及其制备方法
CN1136809A (zh) 制备1-氨基-1，2，3-三唑的方法
CN1283625C (zh) 纯化的lasofoxifene及通过重结晶纯化外消旋lasofoxifene的方法
CN1922188A (zh) 氯吡格雷之药学可接受的盐
CN1518540A (zh) 4-[4-[4-(羟基二苯基甲基)-1-哌啶基]-1-羟基丁基]-α,α-二甲基苯乙酸和其盐酸盐的新型结晶形式
CN1309718C (zh) R－硫辛酸的氨基丁三醇盐的新的变性体及其制备方法
CN1227252C (zh) 制备6－甲基－2－(4－甲基－苯基)－咪唑并[1,2－a]吡啶－3－(N,N－二甲基－乙酰胺)和中间体的方法
CN1314888A (zh) 奥沙奈丹的晶型
CN1890245A (zh) 用于制备微管蛋白抑制剂的方法
CN1176921C (zh) 8-氰基-1-环丙基-7-(1s,6s-2,8-二氮杂双环(4.3.0)壬-8-基)-6-氟-1,4-二氢-4-氧代-3-喹啉羧酸的半盐酸盐
CN1875018A (zh) 制备噻唑烷二酮的方法
CN1882526A (zh) 制备伏格列波糖的方法
CN1366520A (zh) 新型医药
CN1863772A (zh) 制备氮杂双环[3.1.0]己烷化合物的方法
CN1305474A (zh) 帕罗西汀马来酸盐

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20060503